Mortality and treatment response amongst HIV-infected patients 50 years and older accessing antiretroviral services in South Africa

Halima Dawood(Centre for the AIDS Programme of Research in South Africa), Kogieleum Naidoo(Centre for the AIDS Programme of Research in South Africa), Nonhlanhla-Yende Zuma(Centre for the AIDS Programme of Research in South Africa), Razia Hassan-Moosa(Centre for the AIDS Programme of Research in South Africa)
BMC Infectious Diseases
April 10, 2018
10.1186/s12879-018-3083-z
Cited by 43

Related Papers

Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis
|International Journal of Epidemiology|2013|204
High Nasopharyngeal Pneumococcal Density, Increased by Viral Coinfection, Is Associated With Invasive Pneumococcal Pneumonia
|The Journal of Infectious Diseases|2014|197
Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study
|The Lancet HIV|2021|180
Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial
|The Lancet HIV|2020|177
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial
|PLoS Medicine|2018|173